Duan, S.; Li, X.; Han, J.; Yang, Y.; Luo, R.; Cai, Y.; Li, X.; Zheng, Q.; Guo, J.; Liu, R.
Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses. Antioxidants 2024, 13, 256.
https://doi.org/10.3390/antiox13030256
AMA Style
Duan S, Li X, Han J, Yang Y, Luo R, Cai Y, Li X, Zheng Q, Guo J, Liu R.
Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses. Antioxidants. 2024; 13(3):256.
https://doi.org/10.3390/antiox13030256
Chicago/Turabian Style
Duan, Shuni, Xin Li, Junsong Han, Yang Yang, Ranyi Luo, Yajie Cai, Xiaojiaoyang Li, Qi Zheng, Jincheng Guo, and Runping Liu.
2024. "Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses" Antioxidants 13, no. 3: 256.
https://doi.org/10.3390/antiox13030256
APA Style
Duan, S., Li, X., Han, J., Yang, Y., Luo, R., Cai, Y., Li, X., Zheng, Q., Guo, J., & Liu, R.
(2024). Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses. Antioxidants, 13(3), 256.
https://doi.org/10.3390/antiox13030256
